Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis
Authors
Keywords
Cerebrospinal fluid, Alzheimer’s disease, Chemiluminescent enzyme-immunoassay, Assay automation, Amyloïd peptide, Total-Tau
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-10
DOI
10.1007/s00415-019-09418-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
- (2018) Ulf Andreasson et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment
- (2018) Lucilla Parnetti et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Review: Tau in biofluids - relation to pathology, imaging and clinical features
- (2017) H. Zetterberg NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- PET/MR Imaging: New Frontier in Alzheimer's Disease and Other Dementias
- (2017) Xin Y. Zhang et al. Frontiers in Molecular Neuroscience
- Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
- (2016) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- The incidence of post-mortem neurodegenerative and cerebrovascular pathology in mixed dementia
- (2016) Jacques De Reuck et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Dementia in western Europe: epidemiological evidence and implications for policy making
- (2016) Yu-Tzu Wu et al. LANCET NEUROLOGY
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability
- (2015) Anthony Fourier et al. CLINICA CHIMICA ACTA
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
- (2015) Julien Dumurgier et al. Alzheimers Research & Therapy
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting
- (2012) Julien Dumurgier et al. Alzheimers & Dementia
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
- (2011) Anne M. Fagan ARCHIVES OF NEUROLOGY
- Epidemiology of Alzheimer disease
- (2011) Christiane Reitz et al. Nature Reviews Neurology
- Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall
- (2010) Niklas Mattsson et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
- (2010) Christos Davatzikos et al. NEUROBIOLOGY OF AGING
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
- (2009) N A Verwey et al. ANNALS OF CLINICAL BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now